In March 2025, GCCL received an ISO 15189 certification extension approval (KOLAS-accredited medical testing laboratory),
allowing the certification to be maintained until 2029.
ISO 15189, established by the International Organization for Standardization (ISO),
is a globally recognized certification that verifies the quality and technical competence of medical testing laboratories.
It serves as an international standard, ensuring that all clinical trial specimen analyses
meet the highest standards of accuracy, reproducibility, and reliability.
Since obtaining its initial ISO 15189 certification in 2021,
GCCL has continuously enhanced its quality management and technological innovation to provide world-class specimen analysis services.
This four-year certification extension reaffirms that GCCL's clinical trial sample analysis services meet global standards
and uphold the highest levels of accuracy and credibility.
✅ ISO 15189 certification obtained in 2021, followed by continuous quality improvement
✅ The first central lab in Korea to provide full-cycle specimen analysis services, from Phase 1 to regulatory trials
✅ Ongoing enhancement of analytical capabilities for global clinical research and multinational pharmaceutical collaborations
GCCL will continue to provide global-standard sample analysis services as an ISO 15189-certified institution,
leveraging state-of-the-art platforms and a stringent quality management system
to maximize the accuracy and efficiency of clinical trial specimen analysis.
> About GCCL > Newsroom > Company News